Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|August 1, 1987
A urinary metabolite ratio that reflects systemic caffeine clearanceM E Campbell, S P Spielberg, W Kalow
Clinical Pharmacology and Therapeutics|March 1, 1983
Polymorphic N-acetylation of a caffeine metaboliteD M Grant, B K Tang, W Kalow
British Journal of Clinical Pharmacology|April 1, 1984
A simple test for acetylator phenotype using caffeineD M Grant, B K Tang, W Kalow
Clinical Pharmacology and Therapeutics|November 1, 1984
Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansT Inaba, M Jurima, M Nakano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1983
Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in manB K Tang, D M Grant, W Kalow
Journal of Immunological Methods|August 1, 1973
Homogeneous murine myeloma protein-315 and spin-labeled DNP as a model system for spin-labeled hapten titration technique and spin immunoassayJ C Hsia, L T Wong, W Kalow
British Journal of Clinical Pharmacology|December 15, 2004
A simple test for acetylator phenotype using caffeine. 1984D M Grant, B K Tang, W Kalow
Journal of Chromatography|May 31, 1985
Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disordersT P Kruck, W Kalow, D R McLachlan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenaseT Inaba, M Jurima, W A Mahon, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|August 1, 1987
A urinary metabolite ratio that reflects systemic caffeine clearanceM E Campbell, S P Spielberg, W Kalow
Clinical Pharmacology and Therapeutics|March 1, 1983
Polymorphic N-acetylation of a caffeine metaboliteD M Grant, B K Tang, W Kalow
British Journal of Clinical Pharmacology|April 1, 1984
A simple test for acetylator phenotype using caffeineD M Grant, B K Tang, W Kalow
Clinical Pharmacology and Therapeutics|November 1, 1984
Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansT Inaba, M Jurima, M Nakano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1983
Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in manB K Tang, D M Grant, W Kalow
Journal of Immunological Methods|August 1, 1973
Homogeneous murine myeloma protein-315 and spin-labeled DNP as a model system for spin-labeled hapten titration technique and spin immunoassayJ C Hsia, L T Wong, W Kalow
British Journal of Clinical Pharmacology|December 15, 2004
A simple test for acetylator phenotype using caffeine. 1984D M Grant, B K Tang, W Kalow
Journal of Chromatography|May 31, 1985
Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disordersT P Kruck, W Kalow, D R McLachlan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenaseT Inaba, M Jurima, W A Mahon, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.
Pageof 19